Correlation Between Amer Bio and BioAffinity Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amer Bio and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amer Bio and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amer Bio Medica and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Amer Bio and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amer Bio with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amer Bio and BioAffinity Technologies.

Diversification Opportunities for Amer Bio and BioAffinity Technologies

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Amer and BioAffinity is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Amer Bio Medica and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Amer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amer Bio Medica are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Amer Bio i.e., Amer Bio and BioAffinity Technologies go up and down completely randomly.

Pair Corralation between Amer Bio and BioAffinity Technologies

If you would invest  117.00  in bioAffinity Technologies Warrant on September 1, 2024 and sell it today you would lose (45.00) from holding bioAffinity Technologies Warrant or give up 38.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy1.67%
ValuesDaily Returns

Amer Bio Medica  vs.  bioAffinity Technologies Warra

 Performance 
       Timeline  
Amer Bio Medica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amer Bio Medica has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Amer Bio is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
BioAffinity Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Amer Bio and BioAffinity Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amer Bio and BioAffinity Technologies

The main advantage of trading using opposite Amer Bio and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amer Bio position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.
The idea behind Amer Bio Medica and bioAffinity Technologies Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets